IMMP2L and neurodevelopmental disorder: Larger studies, however, indicate that the frequency of IMMP2L deletions (inclusive of exon sequence) in ‘neurotypical’ control populations is often higher (between 0.1% and 1.85%) [36] than those associated with ASD (between 0.27% and 1.54% [36]) and other neurodevelopmental disorders.